Covered Stocks

Andrew Peters

Work

Analyst Andrew Peters is focused on the Healthcare sector with 130 price targets and ratings documented since 2010 spanning on 8 stocks. Previously, Andrew Peters worked at DEUTSCHE BANK, UBS. Analyst's average stock valuation to be materialised ratio is 87.03% with an average time for price targets to be met of 411.75 days.

Most recent stock forecast was given on ESPR, Esperion Therapeutics, Inc at 03-May-2018.

Andrew Peters best performing recommendations are on HALO (HALOZYME THERAPEUTICS, INC).
The best stock recommendation documented was for HALO (HALOZYME THERAPEUTICS, INC) at 11/3/2016. The price target of $12 was fulfilled within 7 days with a profit of $3.54 (41.84%) receiving and performance score of 59.78.

Average potential price target upside

BMRN GILD HALO NBIX ACHN ALXN ESPR PRTA

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

130

$17.8 (15.86%)

122

3 days ago

17/25 (68%)

$34.75 (43.23%)

883

Buy

132

$19.8 (17.65%)

113

13 days ago

19/21 (90.48%)

$14.43 (16.25%)

353

Hold

83

$-29.2 (-26.02%)

70

26 days ago

0/2 (0%)

$-15.03 (-14.00%)

Buy

120

$7.8 (6.95%)

100

2 months 8 days ago

3/4 (75%)

$21.09 (25.40%)

338

Buy

133

$20.8 (18.54%)

133

2 months 12 days ago

5/13 (38.46%)

$32.57 (39.12%)

273

Show more analysts
BMRN GILD HALO NBIX ACHN ALXN ESPR PRTA